RN7SL148P

Across TCGA pan-cancer cohorts, RN7SL148P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL148P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RN7SL148P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL148P expression acts as an unfavorable survival marker, although some lineages such as ESCA and KIRC show a favorable association.

STAD, ESCA, and UVM are the cancer types where RN7SL148P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.063	0.572	<.001	63	view →
ESCA	DFS	Tertile	III,IV	1.000	0.275	.023	18	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
CESC	OS	Tertile	II,III,IV	0.203	0.759	.021	18	view →
THYM	DFS	Tertile	All	0.134	0.871	<.001	9	view →
KIRC	DFS	Tertile	All	1.000	0.616	.034	9	view →
BLCA	OS	Tertile	All	0.228	0.618	.049	9	view →
BRCA	OS	Tertile	II,III,IV	0.772	0.913	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL148P–STAD (DFS)

Open the STAD breakdown →